Regular Article
A Genetic Polymorphism in the Promoter Region of DRD4 Associated with Expression and Schizophrenia

https://doi.org/10.1006/bbrc.1999.0630Get rights and content

Abstract

The human dopamine D4 receptor gene (DRD4) is an important candidate gene for schizophrenia. We identified a novel −521C>T polymorphism in the 5′-promoter region of DRD4. A transient expression method revealed that the T allele of this polymorphism reduces the transcriptional efficiency by 40% compared with the C allele. This polymorphism is of interest because of reported elevation of D4-like sites and DRD4 mRNA in the postmortem schizophrenic brain. The C allele frequency was significantly higher in 252 Japanese schizophrenics (0.48) than in 269 Japanese controls (0.41) (p= 0.02) [odds ratio = 1.35 (95% confidence interval 1.05 – 1.72)]. Although the association is weak and should be considered tentative until other studies replicate it, this polymorphism provides a tool with the potential to examine whether DRD4 is related to susceptibility to and neuroleptic response in schizophrenia.

References (35)

  • T. Sumiyoshi et al.

    Brain Res.

    (1995)
  • P.L. Marzella et al.

    Biol. Psychiatry

    (1997)
  • J. Mulcrone et al.

    Neurosci. Lett.

    (1996)
  • D.A. Roberts et al.

    Schizophrenia Research

    (1996)
  • N.C. Stefanis et al.

    Brain Res. Mol. Brain Res.

    (1998)
  • M. Catalano et al.

    Biol. Psychiatry

    (1993)
  • K. Ohara et al.

    Biological Psychiatry

    (1996)
  • Y. Kohn et al.

    European Neuropsychopharmacology

    (1997)
  • S. Kamakura et al.

    Biochem. Biophys. Res. Commun.

    (1997)
  • D. Campion et al.

    Psychiatr. Res.

    (1994)
  • W. Maier et al.

    Psychiatr. Res.

    (1994)
  • M. Rietschel et al.

    Neuropsychopharmacology

    (1996)
  • H.H. Van Tol et al.

    Nature

    (1991)
  • P. Seeman

    Neuropsychopharmacology

    (1992)
  • P. Seeman et al.

    Nature

    (1993)
  • A.M. Murray et al.

    J. Neurosci.

    (1995)
  • P. Seeman et al.

    European Journal of Pharmacology

    (1995)
  • Cited by (155)

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: 81-298-53-3177 or 3333. E-mail:[email protected].

    View full text